PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31408938-0 2019 Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1. Resveratrol 0-11 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 121-126 35178649-9 2022 Bmal1 mRNA oscillated robustly in AML-12 hepatocytes, but resveratrol treatment led to a phase advance and a decrease in its amplitude, similarly to the effect on Srebp1c and Pgc1alpha mRNA. Resveratrol 58-69 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 0-5 35178649-10 2022 After resveratrol treatment, daily mRNA levels of Bmal1, Sirt1 and Srebp1c were significantly higher. Resveratrol 6-17 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 50-55 31294559-0 2019 Resveratrol Prevents Acrylamide-Induced Mitochondrial Dysfunction and Inflammatory Responses via Targeting Circadian Regulator Bmal1 and Cry1 in Hepatocytes. Resveratrol 0-11 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 127-132 31294559-5 2019 Acrylamide significantly triggered disorders of circadian genes transcription and protein expressions including Bmal1 and Cry 1 in primary hepatocytes, which were prevented by resveratrol pretreatment. Resveratrol 176-187 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 112-117 31294559-6 2019 Moreover, we found that the beneficial effects of resveratrol on stimulating Nrf2/NQO-1 pathway and mitochondrial respiration complex expressions in acrylamide-treated cells were Bmal1-dependent. Resveratrol 50-61 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 179-184 29849897-7 2018 Furthermore, resveratrol, an activator of SIRT1, decreased the acetylation of BMAL1 and inhibited its binding with CRY1, thereby reversing the impaired antioxidative activity induced by 6-OHDA. Resveratrol 13-24 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 78-83 27026610-8 2016 Finally, we used integrative analysis to showcase a potential mechanism-of-action for resveratrol in breast and lung cancer treatment whereby it targets several SMGs (ARNTL, ASPM, CTTN, EIF4G1, FOXP1, and STIP1). Resveratrol 86-97 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 167-172 25309798-0 2014 Effect of Resveratrol, a SIRT1 Activator, on the Interactions of the CLOCK/BMAL1 Complex. Resveratrol 10-21 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 75-80 25309798-11 2014 This inhibitory effect was intensified by treatment with resveratrol, indicating a role for SIRT1 and its activator in CLOCK/BMAL1-mediated transcription of clock genes. Resveratrol 57-68 aryl hydrocarbon receptor nuclear translocator like Homo sapiens 125-130